News

To provide young scholars with an active academic exchange platform for exchanging ideas with each other and with influential experts in cancer metastasis and treatment, and cultivate candidates for Editorial Board of Journal of Cancer Metastasis and Treatment (JCMT), the Editorial Office plans to recruit youth Editorial Board members worldwide from now on.

We are very pleased to announce the successful completion of reorganizing the Editorial Board of JCMT from March to August 2020. During this course, a total of 37 internationally-recognized researchers have formally joined the Editorial Board of JCMT with the ambition to support our future development.

Thank you all for your attention and help to JCMT in the past year.

Editorial office of Journal of Cancer Metastasis and Treatment is delighted to announce that JCMT has adopted MESAs, a brand-new online submission & review system from March 21, 2019, to provide superior publishing experience for our users.

We are pleased to announce that Journal of Cancer Metastasis and Treatment is now a member of the Committee on Publication Ethics (COPE).

We know that many editors, authors, reviewers, and readers are very concerned about the impact of Journal of Cancer Metastasis and Treatment. Then we hereby report the citations of the journal articles. In total, JCMT published 67 and 41 articles in 2016 and 2017, respectively. Among them, 63 and 35 were Review, Original article or Case report in 2016 and 2017, respectively. 31 of these articles were cited 67 times in 2018 by articles indexed in Web of Science (as of January 21, 2019). All the cited articles are listed below.

On January 15, 2019, Annual Report meeting of Journal of Cancer Metastasis and Treatment (JCMT) was held in Beijing, China. The report on the development of the journal over the past year was given by JCMT Editorial Office, which reads as follows.

The continued success of Journal of Cancer Metastasis and Treatment in 2018 depends on the contributions of anonymous but dedicated researchers who providing constructive feedbacks on our manuscripts. These dedicated people give freely of their time and expertise to the journal. Thus, Journal of Cancer Metastasis and Treatment would like to sincerely thank all these professionals in the following who served as reviewers on one or more JCMT manuscripts between January 1, 2018 and December 31, 2018.

On January 25 2018, the 2017 Annual Report Meeting of Journal of Cancer Metastasis and Treatment (JCMT) was held. All members from the editorial office attended this conference, and Carrie Wang, the Managing Editor of the journal made the Annual Report of JCMT to all the attendees.

The 108th American Association for Cancer Research (AACR) Annual Meeting was held in Washingtonfrom April 1 to 5, 2017. Cancer experts and scholars from around the world participated in this grand event. Dandan Yu, Manager Editor of OAE publishing Inc., and Lisa Huang, the Assistant Editor of Journal of Cancer Metastasis and Treatment (JCMT), attended the meeting with the aimsof exchanging opinions with peers and promoting JCMT.

Prostate cancer (PCa) is the fourth most frequent cancer and the second most common cancer in men. Approximately 1.1 million cases of PCa were diagnosed worldwide in 2012, accounting for 15% of all cancers in men [Ferlay et al., Int J Cancer 2015;136:E359e86.]. Although advances in both PCa biology and precision medicine have improved the clinical outcome, the overall impact on survival rates has been relatively modest, leaving metastasised or recurrent disease largely incurable by conventional approaches and requiring the development of better therapeutics.

On January 10, 2017, 2016 Annual Report of Journal of Cancer Metastasis and Treatment was held. As Managing Editor, Lisa Huang presented an overall review of the development of the journal over the past year to all members of the editorial office. A summary of the key events of what has been a very busy year follows.

Univ.-Prof. Dr. Ira-Ida Skvortsova, Laboratory for Experimental and Translational Radiation Oncology (EXTRO-Lab), Dept. of Therapeutic Radiology and Oncology, Medical University of Innsbruck, Anichstr. 35, A-6020 Innsbruck, AUSTRIA; Tel: ++43-512-504-27758 (Lab:-27757); Fax: ++43-512-504-27756; E-Mail: Ira.Skvortsova@i-med.ac.at; Ira.Skvortsova@tirol-kliniken.at

September 12, 2016, this meeting was held. Prof. Dai-Ming Fan discussed every part and provided insightful suggestions as well as gave a great vision that Journal of Cancer Metastasis and Treatment (JCMT)

Academician Yan Sun joins Journal of Cancer Metastasis and Treatment (JCMT) as Honorary Editor-in-Chief on September 23, 2016. This gives us a great impetus again after Academician Dai-Ming Fan joined us.

The 16th Biennial Congress of the Metastasis Research Society (MRS) and the 12th National Congress of the Chinese Society of Tumor Metastasis was held on Sep 15, 2016, in Chengdu, China. The assistant editors (Lisa Huang, Emma Yang, and Lily Wang) of the Journal of Cancer Metastasis and Treatment (JCMT) and Dan-dan Yu, the publication manager of OAE Publishing Inc.

The 19th National Clinical Oncology Congress & Chinese Society of Clinical Oncology (CSCO) was held from September 21–25, 2016, in Xiamen, China. The editorial team (Ling Huang and A-ni Yuan) of the Journal of Cancer Metastasis and Treatment (JCMT) and Dan-dan Yu, the publication manager of OAE Publishing Inc., took part in the conference.

In co-incidence with the AACR Annual Meeting 2016, Journal of Cancer Metastasis and Treatment (JCMT) held its very first Editorial Board meeting on April 16, 2016 at the RUTH’S CHRIS restaurant located at 525 Fulton St, New Orleans, Louisiaa, USA.  The attendees included JCMT Editor-in-Chief

Prof. Yaguang Xi, of Mitchell Cancer Institute, University of South Alabama (Alabama, USA) was invited to visit our Editorial Office of Journal of Cancer Metastasis and Treatment (JCMT) during a short-term academic exchange on August 10, 2015.

Since June, 2015, the Journal of Cancer Metastasis and Treatment (JCMT) has established a preliminary cooperation with European Organization for Research and Treatment of Cancer (EORTC) in terms of mutual contact and advertisement.